# Feasibility of One-Step Sentinel Lymph Node (SLN) Biopsy With Radiolabeled Methylene Blue (IND 70,627)

> **NCT00784849** · PHASE2 · COMPLETED · sponsor: **Louisiana State University Health Sciences Center in New Orleans** · enrollment: 62 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Methylene blue

## Key facts

- **NCT ID:** NCT00784849
- **Lead sponsor:** Louisiana State University Health Sciences Center in New Orleans
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-11
- **Primary completion:** 2011-06
- **Final completion:** 2011-06
- **Target enrollment:** 62 (ACTUAL)
- **Last updated:** 2012-06-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00784849

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00784849, "Feasibility of One-Step Sentinel Lymph Node (SLN) Biopsy With Radiolabeled Methylene Blue (IND 70,627)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00784849. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*